{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T15:16:04Z","timestamp":1770995764228,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,2,9]],"date-time":"2005-02-09T00:00:00Z","timestamp":1107907200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2005,2,9]],"date-time":"2005-02-09T00:00:00Z","timestamp":1107907200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This is a report on a 37-patient continuation study of the open ended, Omega-3 Fatty Acid (O-3FA) add-on study. Subjects consisted of the original 19 patients, along with 18 new patients recruited and followed in the same fashion as the first nineteen. Subjects carried a DSM-IV-TR diagnosis of Bipolar Disorder and were visiting a Mood Disorder Clinic regularly through the length of the study. At each visit, patients' clinical status was monitored using the Clinical Monitoring Form. Subjects reported on the frequency and severity of irritability experienced during the preceding ten days; frequency was measured by way of percentage of days in which subjects experienced irritability, while severity of that irritability was rated on a Likert scale of 1 \u2013 4 (if present). The irritability component of Young Mania Rating Scale (YMRS) was also recorded quarterly on 13 of the 39 patients consistently. Patients had persistent irritability despite their ongoing pharmacologic and psychotherapy.<\/jats:p><jats:p>Omega-3 Fatty Acid intake helped with the irritability component of patients suffering from bipolar disorder with a significant presenting sign of irritability. Low dose (1 to 2 grams per day), add-on O-3FA may also help with the irritability component of different clinical conditions, such as schizophrenia, borderline personality disorder and other psychiatric conditions with a common presenting sign of irritability.<\/jats:p>","DOI":"10.1186\/1475-2891-4-6","type":"journal-article","created":{"date-parts":[[2005,2,10]],"date-time":"2005-02-10T07:29:00Z","timestamp":1108020540000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Omega-3 fatty acids decreased irritability of patients with bipolar disorder in an add-on, open label study"],"prefix":"10.1186","volume":"4","author":[{"given":"Kemal","family":"Sagduyu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet E","family":"Dokucu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce A","family":"Eddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"Craigen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia F","family":"Baldassano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ay\u015feg\u00fcl","family":"Y\u0131ld\u0131z","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,2,9]]},"reference":[{"issue":"5","key":"53_CR1","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0006-3223(97)00206-0","volume":"43","author":"M Peet","year":"1998","unstructured":"Peet M, Murphy B, Shay J, Horrobin D: Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry. 1998, 43 (5): 315-319. 10.1016\/S0006-3223(97)00206-0.","journal-title":"Biol Psychiatry"},{"issue":"10","key":"53_CR2","first-page":"28","volume":"19","author":"J Lake","year":"2002","unstructured":"Lake J: Omega-3 Fatty Acids: Theory, Clinical Trials and Safety Issues. Psychiatric Times. 2002, 19 (10): 28-34.","journal-title":"Psychiatric Times"},{"issue":"3","key":"53_CR3","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1176\/appi.ajp.159.3.477","volume":"159","author":"B Nemets","year":"2002","unstructured":"Nemets B, Stahl Z, Belmaker RH: Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry. 2002, 159 (3): 477-479. 10.1176\/appi.ajp.159.3.477.","journal-title":"Am J Psychiatry"},{"issue":"4","key":"53_CR4","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1172\/JCI118507","volume":"97","author":"T Hamazaki","year":"1996","unstructured":"Hamazaki T, Sawazaki S, Itomura M, Asaoka E, Nagao Y, Nishimura N, Yazawa K, Kuwamori T, Kobayashi M: The effect of docosahexaenoic acid on aggression in young adults. A placebo-controlled double-blind study. J Clin Invest. 1996, 97 (4): 1129-1133.","journal-title":"J Clin Invest"},{"issue":"3","key":"53_CR5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1017\/S1092852900009020","volume":"9","author":"T Deckersbach","year":"2004","unstructured":"Deckersbach T, Perlis RH, Frankle WG, Gray SM, Grandin L, Dougherty DD, Nierenberg AA, Sachs GS: Presence of irritability during depressive episodes in bipolar disorder. CNS Spectr. 2004, 9 (3): 227-231.","journal-title":"CNS Spectr"},{"issue":"5","key":"53_CR6","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1176\/appi.ajp.160.5.996","volume":"160","author":"LB Marangell","year":"2003","unstructured":"Marangell LB, Martinez JM, Zboyan HA, Kertz B, Kim HF, Puryear LJ: A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry. 2003, 160 (5): 996-998. 10.1176\/appi.ajp.160.5.996.","journal-title":"Am J Psychiatry"},{"issue":"suppl 1","key":"53_CR7","first-page":"58","volume":"5","author":"PE Keck","year":"2003","unstructured":"Keck PE, McElroy SL, Freeman MP: Randomized, placebo-controlled trial of eicosapentaenoic acid in bipolar depression. Bipolar Disord. 2003, 5 (suppl 1): 58-","journal-title":"Bipolar Disord"},{"issue":"suppl 1","key":"53_CR8","first-page":"58","volume":"5","author":"PE Keck","year":"2003","unstructured":"Keck PE, McElroy SL, Freeman MP: Randomized, placebo-controlled trial of eicosapentaenoic acid in rapid cycling bipolar disorder. Bipolar Disord. 2003, 5 (suppl 1): 58-","journal-title":"Bipolar Disord"},{"issue":"5","key":"53_CR9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1001\/archpsyc.56.5.407","volume":"56","author":"AL Stoll","year":"1999","unstructured":"Stoll AL, Severus WE, Freeman MP, Rueter S, Zboyan HA, Diamond E, Cress KK, Marangell LB: Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry. 1999, 56 (5): 407-412. 10.1001\/archpsyc.56.5.407.","journal-title":"Arch Gen Psychiatry"},{"issue":"11","key":"53_CR10","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1002\/gps.1203","volume":"19","author":"A Mirakhur","year":"2004","unstructured":"Mirakhur A, Craig D, Hart DJ, McLlroy SP, Passmore AP: Behavioural and psychological syndromes in Alzheimer's disease. Int J Geriatr Psychiatry. 2004, 19 (11): 1035-1039. 10.1002\/gps.1203.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"6 Pt 1","key":"53_CR11","first-page":"525","volume":"28","author":"K McHichi alami","year":"2002","unstructured":"McHichi alami K, Tahiri SM, Moussaoui D, Kadri N: [Assessment of premenstrual dysphoric disorder symptoms: population of women in Casablanca]. Encephale. 2002, 28 (6 Pt 1): 525-530.","journal-title":"Encephale"},{"issue":"1","key":"53_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1176\/appi.ajp.160.1.167","volume":"160","author":"MC Zanarini","year":"2003","unstructured":"Zanarini MC, Frankenburg FR: omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study. Am J Psychiatry. 2003, 160 (1): 167-169. 10.1176\/appi.ajp.160.1.167.","journal-title":"Am J Psychiatry"},{"issue":"2","key":"53_CR13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11745-004-1209-3","volume":"39","author":"GS Young","year":"2004","unstructured":"Young GS, Maharaj NJ, Conquer JA: Blood phospholipid fatty acid analysis of adults with and without attention deficit\/hyperactivity disorder. Lipids. 2004, 39 (2): 117-123.","journal-title":"Lipids"},{"issue":"3","key":"53_CR14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/sj.ejcn.1601830","volume":"58","author":"S Hirayama","year":"2004","unstructured":"Hirayama S, Hamazaki T, Terasawa K: Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit\/hyperactivity disorder - a placebo-controlled double-blind study. Eur J Clin Nutr. 2004, 58 (3): 467-473. 10.1038\/sj.ejcn.1601830.","journal-title":"Eur J Clin Nutr"},{"issue":"3","key":"53_CR15","first-page":"9","volume":"20","author":"K Sagduyu","year":"2003","unstructured":"Sagduyu K: Omega-3 Fatty Acids for Irritable Mood? . Psychiatric Times. 2003, 20 (3): 9-","journal-title":"Psychiatric Times"},{"key":"53_CR16","unstructured":"Diagnostic and Statistical Manual of Mental Disorders, Text Revision. 2000, Washington, D.C. , American Psychiatric Association, 4th"},{"issue":"5","key":"53_CR17","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1034\/j.1399-5618.2002.01195.x","volume":"4","author":"GS Sachs","year":"2002","unstructured":"Sachs GS, Guille C, McMurrich SL: A clinical monitoring form for mood disorders. Bipolar Disord. 2002, 4 (5): 323-327. 10.1034\/j.1399-5618.2002.01195.x.","journal-title":"Bipolar Disord"},{"key":"53_CR18","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1192\/bjp.133.5.429","volume":"133","author":"RC Young","year":"1978","unstructured":"Young RC, Biggs JT, Ziegler VE, Meyer DA: A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978, 133: 429-435.","journal-title":"Br J Psychiatry"},{"issue":"10","key":"53_CR19","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1176\/ajp.161.10.1922","volume":"161","author":"F Hirashima","year":"2004","unstructured":"Hirashima F, Parow AM, Stoll AL, Demopulos CM, Damico KE, Rohan ML, Eskesen JG, Zuo CS, Cohen BM, Renshaw PF: Omega-3 fatty acid treatment and T(2) whole brain relaxation times in bipolar disorder. Am J Psychiatry. 2004, 161 (10): 1922-1924. 10.1176\/appi.ajp.161.10.1922.","journal-title":"Am J Psychiatry"},{"issue":"4","key":"53_CR20","first-page":"5","volume":"35","author":"R Ryback","year":"2001","unstructured":"Ryback R: Bioelectrical modulators and the cell membrane in psychiatric medicine. Psychopharmacol Bull. 2001, 35 (4): 5-44.","journal-title":"Psychopharmacol Bull"},{"issue":"1","key":"53_CR21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1475-2891-3-20","volume":"3","author":"J Bradbury","year":"2004","unstructured":"Bradbury J, Myers SP, Oliver C: An adaptogenic role for omega-3 fatty acids in stress; a randomised placebo controlled double blind intervention study (pilot)ISRCTN22569553. Nutr J. 2004, 3 (1): 20-10.1186\/1475-2891-3-20.","journal-title":"Nutr J"},{"issue":"1","key":"53_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0022-3956(01)00048-6","volume":"36","author":"M Peet","year":"2002","unstructured":"Peet M, Horrobin DF: A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms. J Psychiatr Res. 2002, 36 (1): 7-18. 10.1016\/S0022-3956(01)00048-6.","journal-title":"J Psychiatr Res"},{"issue":"11","key":"53_CR23","first-page":"41","volume":"86","author":"GA Plotnikoff","year":"2003","unstructured":"Plotnikoff GA: Food as medicine--cost-effective health care? The example of omega-3 fatty acids. Minn Med. 2003, 86 (11): 41-45.","journal-title":"Minn Med"},{"issue":"1","key":"53_CR24","first-page":"133","volume":"70","author":"MB Covington","year":"2004","unstructured":"Covington MB: Omega-3 fatty acids. Am Fam Physician. 2004, 70 (1): 133-140.","journal-title":"Am Fam Physician"}],"container-title":["Nutrition Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2891-4-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/1475-2891-4-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2891-4-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2891-4-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T13:04:25Z","timestamp":1728306265000},"score":1,"resource":{"primary":{"URL":"https:\/\/nutritionj.biomedcentral.com\/articles\/10.1186\/1475-2891-4-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2,9]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2005,12]]}},"alternative-id":["53"],"URL":"https:\/\/doi.org\/10.1186\/1475-2891-4-6","relation":{},"ISSN":["1475-2891"],"issn-type":[{"value":"1475-2891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2,9]]},"assertion":[{"value":"30 November 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"6"}}